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In November of 2015, the Ministry of Health of Brazil published an announcement conﬁrming
the  relationship between Zika virus and the microcephaly outbreak in the Northeast, sug-
gesting that infected pregnant women might have transmitted the virus to their fetuses.
The  objectives of this study were to conduct a literature review about Zika virus infection
and  microcephaly, evaluate national and international epidemiological data, as well as the
current recommendations for the health teams. Zika virus is an arbovirus, whose main
vector is the Aedes sp. The main symptoms of the infection are maculopapular rash, fever,
non-purulent conjunctivitis, and arthralgia. Transmission of this pathogen occurs mainly
by  mosquito bite, but there are also reports via the placenta. Microcephaly is deﬁned as a
measure of occipto-frontal circumference being more than two standard deviations below
the  mean for age and gender. The presence of microcephaly demands evaluation of the
patient, in order to diagnose the etiology. Health authorities issued protocols, reports and
notes concerning the management of microcephaly caused by Zika virus, but there is still
controversy about managing the cases. The Ministry of Health advises notifying any sus-
pected or conﬁrmed cases of children with microcephaly related to the pathogen, which is
conﬁrmed by a positive speciﬁc laboratory test for the virus. The ﬁrst choice for imaging
exam in children with this malformation is transfontanellar ultrasound. The most effective
way to control this outbreak of microcephaly probably caused by this virus is to combat the
vector. Since there is still uncertainty about the period of vulnerability of transmission via
placenta, the use of repellents is crucial throughout pregnancy. More investigations studyingthe  consequences of this 
are required.
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ntroduction
n November of 2015, the Ministry of Health (MOH) of Brazil
ssued a bulletin conﬁrming the relationship between Zika
irus (ZIKV) infection and the microcephaly outbreak in the
ortheastern region.1
One of the ﬁrst records of ZIKV disease in the coun-
ry is from March of 2015, in the state of Bahia, Northeast
razil, in which patients with “dengue-like syndrome” showed
ositivity in blood analysis by molecular biology (real time
CR-RT-PCR).2 Autochthonous transmission by ZIKV was con-
rmed in Brazil in April 20153 and in May of the same year, the
razilian MOH  conﬁrmed the circulation of the virus.4
From an obstetric perspective, in October of 2015 there
as an unusual increase in the number of newborns with
icrocephaly in the state of Pernambuco (Northeast). Consid-
ring that some of the mothers of these babies had a rash
uring pregnancy5 the possibility of ZIKV transmission from
other to child, causing neurological defects in the child, was
uggested. After conducting tests in a baby born with micro-
ephaly and other malformations in one of the Northeastern
tates, the presence of the virus in blood and tissues of the
atient was detected, proving that assumption.4
Currently, due to the progressive extension of cases of
icrocephaly, corresponding to 4783 suspected and 404 con-
rmed cases,6 this situation became extremely concerning to
ublic health, since only 18% of the infected are symptomatic4
nd there is no treatment for this condition.7 Therefore, the
ontrol of pregnant women who  might bear a child with micro-
ephaly is impaired, and consequently, a strict monitoring
uring prenatal care is needed.
In view of this new and alarming scenery, this study aimed
o conduct a literature review about ZIKV and microcephaly,
valuate epidemiological data published until February 5th
016 in national and international levels, as well as to review
he current recommendations for the health teams.
ika  virus
he ZIKV is an arbovirus (arthropod-born virus), since
art of its reproductive cycle occurs within the body of
ematophagous insets. They belong to the Flaviviridae fam-
ly, and Flavivirus genus, whose members are composed by a
rotein capsid involved by a lipid envelope, in which the mem-
rane protein and glycoprotein spikes are inserted. The Aedes
p. mosquitoes are the vectors responsible for transmitting
his microorganism, as well as Chikungunya virus (CHIKV),
engue virus (DENV), yellow fever virus (YFV), and West Nile
ever virus (WNV).8
The ZIKV was initially isolated in a Rhesus monkey, at the
frican Zika forest in Uganda. In the 60s, the ﬁrst cases of ZIKV
nfection in humans have been conﬁrmed by serologic evi-
ence in the countries of Uganda, Nigeria, and Senegal.9 The
issemination was so great that in 2007 the ﬁrst outbreak out-
ide Africa and Asia was reported, on the Yap Island (Federated
tates of Micronesia). In October of 2013, the largest ZIKV out-
reak affected approximately 28,000 inhabitants of the French
olynesia.8 After two years, in May 2015 the Brazilian MOH
ssued a statement conﬁrming the ﬁrst cases identiﬁed in the6;2 0(3):282–289 283
country: 16 people in the Northeast, at Bahia and Rio Grande
do Norte states, were tested positive for the virus.4
The condition of ZIKV infection is named “dengue-like
syndrome” because it resembles an infection caused by the
DENV.9 The clinical criteria for diagnosing this self-limited
disease are pruritic maculopapular rash plus at least two
of the following: fever (generally low grade fever lasting 1–2
days), non-purulent conjunctivitis, polyarthralgia, and periar-
ticular swelling.10 Other signs and symptoms may be present,
such as muscle pain, retroocular pain, vomiting, and lymph
node hypertrophy.9 Besides, ZIKV infection can affect the
central nervous system (CNS). There are reports of a 20-fold
increase in the incidence of Guillain–Barre Syndrome (GBS) in
Micronesia during the outbreak of ZIKV, in addition to cases
of GBS after infection by this pathogen in French Polynesia.11
However, about 80% of infections are asymptomatic, what
makes the diagnosis and prevention of transmission highly
challenging.12
The detection of viral RNA in the acute phase – up to 10 days
from onset of symptoms – by RT-PCR assay is the method of
choice for identiﬁcation of the virus so far. Fortunately, stud-
ies to improve the identiﬁcation of immunoglobulin (IgM) by
ELISA are being carried out, but cross-reaction with the DENV
is likely to occur in endemic areas of dengue fever.5,13 More-
over, another study suggested the possibility of diagnosing the
infection from urine samples. Viral RNA was isolated even
after 10 days of onset of symptoms, which shows that this
technique is suitable for later diagnosis when compared with
tests using blood samples.14
Transmission
ZIKV is mainly transmitted by the Aedes aegypti vector, which
resides in tropical and subtropical regions, as well as by the
Aedes albopictus,  inhabitant of the European Mediterranean.
After the mosquito’s bite, there is an incubation period of
about nine days, and then the symptoms ensue.15,16
Although there is no evidence of sexual transmission in
humans by other arboviruses, some authors hypothesized
that this could be possible for ZIKV. Patients exposed to
endemic areas showed symptoms of the disease and one atyp-
ical signal of hematospermia. In such cases, the presence of
virus in semen was conﬁrmed by serological tests or by RT-
PCR. In addition, one of the sexual partners of these patients
had similar symptoms, strengthening this assumption.8,16
During the outbreak in French Polynesia, a study to inves-
tigate ZIKV in blood donors was carried out using RT-PCR
modiﬁed technique. It was noted that 3% of donors were
asymptomatic hosts of the virus, but no case of infection was
identiﬁed after blood transfusion. Still, the results suggest that
testing for ZIKV must be implemented in the routine of blood
donation.15,17
Regarding perinatal transmission, which is the main focus
of this review article, on November 17th 2015 investiga-
tors of the Oswaldo Cruz Institute (OCI/Fiocruz) detected the
presence of ZIKV genome in amniotic ﬂuid samples of two
pregnant women in the state of Paraiba (Northeast), in whom
ultrasound exams had conﬁrmed microcephalic fetuses.18
This fact taken in isolation does not conﬁrm transplacental
i s . 2 0 1 6;2  0(3):282–289
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Fig. 1 – Suspected cases of microcephaly. Graph showing
the progressive prevalence of suspected cases of
microcephaly occurring in Brazil from the beginning of the
3670 are under investigation, 404 have been conﬁrmed, and
704 were discarded from surveillance.6
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Fig. 2 – Affected federal units. Graph showing the284  b r a z j i n f e c t d 
transmission of the virus but is highly suggestive, since most
of the pathogens that cause infections in pregnancy, such as
toxoplasmosis, can be detected in the amniotic ﬂuid.19
At the same time, the French Polynesian authorities
reported a signiﬁcant increase in cases of CNS malformations
in fetuses born between 2014 and 2015, which was the period
of ZIKV outbreak in the region.20 In this nation, a study20 sug-
gests that other forms of contagion, such as milk and saliva,
ought to be considered. This was evidenced in cases in which
RT-PCR was positive for ZIKV in mother’s milk, and baby’s and
mother’s saliva, but when inoculated in Vero cells the viruses
did not replicate. However, since this kind of transmission
can occur in other arboviral diseases, like dengue21 and West
Nile fever,22 these possibilities of contamination should not
be neglected.
One of the concerns about the infection in women is the
virus latency period, because it is not known if a virus acquired
in a non-pregnant woman could have a potential impact
on a future fetus. That is why some protocols highlight the
importance of also notifying cases in which women have expe-
rienced symptoms 40 days before pregnancy.23
Microcephaly
Microcephaly is deﬁned as the measurement of head
occipto-frontal circumference being more  than two standard
deviations below the mean for age and gender.24 It is known
that the brain of microcephalic patients is proportionally
smaller, thus about 90% of the cases are associated with some
degree of intellectual disability.5 It is important to remind that
microcephaly is not a diagnosis but a clinical ﬁnding, therefore
further investigation is necessary when facing this situation.25
Regarding the initiation, microcephaly can be classiﬁed as
primary (congenital) or secondary (postnatal). Primary micro-
cephaly can be detected before 36 weeks of gestation. This
may occur by failure or reduction of neurogenesis, by destruc-
tive pre-natal insults or by very early degenerative processes.25
The secondary microcephaly is caused by any insult factor in
the development and function of the CNS. It associates com-
monly with neurological disorders.25
The etiological approach of microcephaly is extensive, as
this can be caused by many  genetic, environmental, and
maternal factors.5 Not infrequently, genetic microcephaly
progresses with dysmorphic features or concomitantly with
other congenital abnormalities and it is very common the
association with syndromes, as in Down Syndrome.5,25,26
As for environmental and maternal factors, there are
hypoxic ischemic insults, placental insufﬁciency, systemic
and metabolic disorders, exposure to teratogens during preg-
nancy, pregnant women with severe malnutrition, maternal
phenylketonuria, and CNS infections (such as rubella, con-
genital toxoplasmosis, cytomegalovirus infection, herpes, and
HIV).5,25 However, in some cases, the etiology of microcephaly
cannot be deﬁned (idiopathic).25
Concomitantly with the increase in cases of microcephaly
notiﬁed by MOH, there was an outbreak of ZIKV infection,
which was listed as a possible cause of that malformation.20
According to information reported by the Brazilian live births
information system (SINASC), the extension of the 2015Zika virus outbreak until January 30, 2016.6,29–38
situation becomes even more  signiﬁcant compared to previous
years. From 2010 to 2014 there were around 150 cases reported
per year in the country, and currently, suspected cases totaled
4783.6,27 Six months have elapsed between the ﬁrst virus
transmission reports (May 2015) and microcephaly outbreak
(November 2015), which is the appropriated time for diagnos-
ing cranial abnormalities by prenatal ultrasound examination,
suggesting a temporal correlation. The increase in cases of
microcephaly occurred in the same area where there had been
circulation of virus, indicating also a place correspondence.27
As a result of the increasing impact of this scenery, the
MOH deployed the Emergency Operations Center on Health
Issues (COES) on November 10th 2015, and after one day,
declared “Public Health Emergency of National Importance”.28
The COES weekly publishes epidemiological reports, making
it possible to compare and observe a large growth in the num-
ber of suspected cases of microcephaly (Fig. 1), and also the
progressive involvement of other Brazilian states in different
regional areas (Figs. 2 and 3). Of the total of suspected cases,progressive prevalence of suspected cases of microcephaly
according to the number of Brazilian states, or Federal
units, affected from the beginning of the Zika virus
outbreak until January 30, 2016.6,29–38
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Fig. 3 – Suspected deaths. Graph exhibiting the progressive
prevalence of suspected deaths related with microcephaly
caused by the ZIKV occurring in Brazil from the beginning
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Scientiﬁc evidence support the relation between ZIKV
nfection and microcephaly. The literature describes neu-
otropism as a characteristic of ZIKV in laboratory tests
nvolving rats.39 This fact endorses the hypothesis that the
irus directly acts on nerve cells of the fetus. Yet, another
ossibility is that the mechanism occurs through the immune
ystem, such as in Guillain–Barre condition, where antibodies
re formed against neuronal myelin sheath.40
Different arboviruses have also shown neurological con-
equences in perinatal infections, such as encephalopathy
y CHIKV in humans41 and necrotizing encephalopathy and
hite matter vacuolization by the Akabane virus in sheep and
oats.42 In addition, arboviruses can cause meningitis, myeli-
is, neuritis, producing symptoms such as headache, fever,
omiting, peripheral neuropathy, seizures, and even Parkin-
onism and chronic epilepsy.43
Other facts also corroborate this association. In Novem-
er 2015, the Evandro Chagas Institute declared the presence
f ZIKV genome in blood and tissues of a baby with micro-
ephaly, who  died 5 min  after birth.1,20 Likewise, according to
he epidemiological reports of COES, the number of deaths
ssumed to be associated with this deformity has expanded
igniﬁcantly since this case. Among the 76 suspected cases, 15
ere conﬁrmed.6
Furthermore, analysis of medical records and interviews
ith 60 women, who presented a rash during their pregnancy
nd whose babies were born with microcephaly, showed an
bsence of other genetic disorders in the family and of ﬁndings
hat might suggest others infections. Thus, the exanthema-
ous disease is probably the putative cause of this deformity.44
In spite of the relation between microcephaly and ZIKV
nfection being established in Brazil, some epidemic countries,
uch as Micronesia and New Calendonia, showed no raise in
he number of congenital CNS deformities. It is worth remem-
ering that, however, such sites have considerably smaller
opulation as well as less registered cases, making their
27imited sample difﬁcult to analyze.
The microcephaly is an anomaly in which the skull growth
s limited due to the lack of stimulation as a result of the deﬁcit
n the brain growth.45 The ﬁrst trimester of pregnancy is when6;2 0(3):282–289 285
there is greatest risk that some external factor would cause
malformations in the developing child. But when it comes
to the CNS, the risk exists throughout pregnancy.5 According
to analyses carried out in Brazil, the risk of microcephaly or
congenital abnormalities in newborns associated with ZIKV
is greater when the infection occurs in the ﬁrst trimester of
pregnancy.20,27 Health authorities of French Polynesia sug-
gested that the critical interval would be during the ﬁrst or
second trimesters.20,27 Nevertheless, the gestational period of
major vulnerability remains unknown.
Moreover, it has been suggested that microcephaly related
to ZIKV could be more  aggressive. According to a research with
a cohort of 35 babies that were born with microcephaly in
Brazilian affected areas, 71% of them had this abnormality
in a severe level.46 Consequently, depending on the inten-
sity, it could lead to seizures, hearing and vision impairment,
intellectual disability, developmental impairment, and even a
life-threatening condition.47
Detecting,  monitoring  and  managing
Whereas ZIKV infection became a public health emergency,
the Brazilian MOH and several state health departments have
published protocols, reports and notes concerning the diag-
nosis and management of congenital microcephaly. As it is a
recent condition, there is still much controversy about guide-
lines and dynamic ﬂowcharts. For this part of the review,
we selected technical reports of State Departments of Health
(SESA) of two states considered of great importance in this epi-
demiological situation: São Paulo and Pernambuco, in addition
to the MOH  protocols.
The MOH published the “Surveillance Protocol in Response
to the Occurrence of Microcephaly related to the ZIKV Infec-
tion”. This document advises that the presence of exanthema
in a pregnant woman, regardless of gestational age, features
a suspected case of Zika virus infection, after ruling out other
infectious and non-infectious causes. The conﬁrmation is
made by a speciﬁc positive laboratory test for the pathogen.
The MOH  recommends two blood samples of the pregnant
woman under investigation: the ﬁrst collected three to ﬁve
days after the onset of symptoms and the second two to four
weeks after the ﬁrst sample. The material will only be ana-
lyzed by PCR if the serology is positive. The ZIKV-speciﬁc IgM
antibodies can be detected by ELISA or immunoﬂuorescence
assays in serum specimens from day ﬁve after the onset of
symptoms. However, there are no commercial kits for sero-
logical diagnosis of ZIKV.44,48
The management of pregnant women with suspicion of
ZIKV infection differs slightly between the SESA of Pernam-
buco, the SESA of Sao Paulo, and recommendations by the
MOH. According to the SESA of Pernambuco, it is necessary to
collect a blood sample within ﬁve days of the onset of symp-
toms and a urine sample within eight days, then repeat blood
sampling 14–21 days after the start of clinical symptoms.
These samples will be analyzed by serology and molecular
biology for ZIKV. Still, for this group of pregnant women  it
is recommended an ultrasound examination between the
32 and 35 weeks of gestation regardless of laboratory test
results.5 For the São Paulo SESA, the only difference from
i s . 2 0286  b r a z j i n f e c t d 
the MOH  recommendations is that the second blood drawing
should be done 3–4 weeks after the onset of symptoms.49
For the pregnant women with no history of skin rash and
who  gave birth to a child with microcephaly, the MOH recom-
mends collecting a mother’s blood sample at the time of
diagnosis of the child’s malformation, and a second blood col-
lection 2–4 weeks after the ﬁrst sample.44 The report of São
Paulo State determines that the second test should be done 3–4
weeks after the ﬁrst collection,49 while Pernambuco’s Protocol
does not specify about this lay-off.5
The diagnosis of microcephaly can be made during the
prenatal and/or postnatal periods. According to the MOH
recommendations a case should deemed suspected during
pregnancy when the fetus presents head circumference (HC)
with two standard deviations below the mean for gestational
age or when there is an ultrasound ﬁnding with CNS alter-
ation suggestive of congenital infection. Any suspected case
of microcephaly caused by ZIKV should be immediately noti-
ﬁed to health authorities. In order to conﬁrm, it is necessary
to rule out other infectious and non-infectious causes or per-
form laboratory tests.44 The Pernambuco’s Protocol propose
that, if there is positivity in these tests, the health profes-
sional must issue a notiﬁcation to the local health authorities,
explain the ultrasound ﬁndings to the mother, evaluate the
need for repeating the ultrasound, keep prenatal care routine
– as isolated microcephaly does not characterize pregnancy
as high risk – and guide the pregnant woman to psychosocial
support by a multidisciplinary team of the health unit.5 The
São Paulo SESA does not specify the correct approach to a case
of microcephaly during prenatal care.49
On the other hand, the postnatal diagnosis used to be deter-
mined by the cutoff of HC value lower or equal to 33 cm.  But
recently the MOH  decreased this number to less than or equal
to 32 cm,  the same value proposed by the WHO,  consequently
avoiding unnecessary exposure to potentially harmful tests
in children with normal skull. When the HC of the newborn
is below the third percentile or less than or equal to 32 cm,
it is considered a suspected case associated with ZIKV infec-
tion, and it is conﬁrmed through positive samples for the virus
in the newborn or in the mother during pregnancy. Babies
with congenital microcephaly should have samples of blood,
umbilical cord, cerebrospinal ﬂuid, and placenta collected at
birth and analyzed by ZIKV serology, which, if positive, should
be further subjected to molecular biology analysis.44 The
preferred imaging exam is transfontanellar ultrasonography
(US-TF) in order to avoid exposure to computed tomography
scan (CT-scan). For those babies who  present early-closing
fontanel or if the suspicion persists after diagnostic laboratory
and imaging tests, cranial CT-scan without contrast should be
performed.50 However, the São Paulo SESA recommends the
execution of laboratory tests involving merely the umbilical
cord, placenta, and cerebrospinal ﬂuid (CSF).49 On the other
hand, the Pernambuco SESA advise that only CSF and blood
of the fetus and the mother’s blood should be tested, and the
ﬁrst imaging evaluation to be done is cranial CT scan without
contrast.5As stated, suspected and conﬁrmed cases of microcephaly
related to ZIKV infection must be notiﬁed. The notiﬁcation
shall be recorded in the online form of Public Health Event
Log (RESP-Microcefalias), available on www.resp.saude.gov.br 1 6;2  0(3):282–289
and SINASC online system. This is extremely important for
epidemiological understanding of the features of this viral
infection, since this data will be stored in a governmental
database.44
The MOH endures the operation of nonspeciﬁc laboratory
tests for newborns with microcephaly, which are: complete
blood count, serum levels of liver aminotransferases, direct
and indirect bilirubin, urea, creatinine, and indicators of
inﬂammatory activity, as well as an abdominal ultrasound and
echocardiography.44 The Pernambuco SESA also recommends
rapid test for syphilis and/or VDRL.5 The technical report of
the State of São Paulo does not specify which laboratory tests
must be made in the newborn.49
Additionally, as microcephaly may be related to neurode-
velopmental disorders, the Auditory Evoked Potential testing
(BAEP) should be performed as the ﬁrst choice for hearing
assessment, in addition to the Ocular Neonatal Screening
Test, for ophthalmic evaluation, and the Biological Newborn
Screening Test.50 The São Paulo SESA does not specify any of
these tests,49 while Pernambuco SESA emphasizes the impor-
tance of ophthalmologic examination with fundoscopy in
newborns with microcephaly.5
A case of stillbirth with microcephaly at any gestational age
is deemed suspected if the mother had a history of rash illness
during pregnancy. Any suspected cases must be reported, and
should undergo conﬁrmation tests for ZIKV identiﬁcation in
the mother or fetal tissue. For this purpose, the MOH  recom-
mends collecting samples of 1 cm3 from the child’s organs
(brain, liver, heart, lung, kidney and spleen) and 3 cm3 from the
placenta for molecular and immunohistochemistry biology
tests, in addition to the serological evaluation of the mother.44
In regard to this detection, the Pernambuco’s Protocol also
recommends that baby’s tissue samples and placenta should
be collected but it does not mention the mother’s serum
testing,5 while the São Paulo SESA has no recommendation
on stillbirths in its technical report.49
In case of a positive history for rash during pregnancy fol-
lowed by an abortion, the MOH considers it as a suspected
abortion related to ZIKV infection. It is conﬁrmed only when
the pathogen is identiﬁed in maternal or fetal tissue. There-
fore, it is necessary to collect samples in the same way as for
the cases of stillbirths with ZIKV related microcephaly.44 The
São Paulo and Pernambuco SESA have not published recom-
mendations for this situation.5,49
The most effective plan to combat this outbreak of micro-
cephaly possibly caused by ZIKV is the prevention, ﬁghting the
Aedes sp. mosquito by eradicating their breeding grounds.51
It is essential for the community to be oriented on the con-
trol of mosquito proliferation in urban and peri-urban areas.
For this reason, public health actions, such as home visits by
health professionals, advising and guiding the population to
eliminate vector sources inside the houses should be imple-
mented. Additionally, using insecticides sprayed by vehicles
on public roads and urban sanitation campaigns should be
contemplated.44,52
The MOH  endorses instructing fertile women, who wish to
have a child, about the current situation of microcephaly in
the country.5,50 Health authorities do not request to postpone
pregnancy, although there is discussion regarding this subject,
especially for young couples who could plan for pregnancy
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fter best knowledge and control of this virus. It is impor-
ant for healthcare professionals to inform the population
n general about the disease, belying unofﬁcial information
nd checking the ofﬁcial data from epidemiological bulletins
eleased weekly (available in www.saude.gov.br/sus). More-
ver, it is particularly important to make an early diagnosis
f microcephaly and recognize possible brain dysfunctions to
uide the patient to a healthcare unit that can implement early
rain stimulation measures.50
Furthermore, for personal protection, mainly for pregnant
omen, the MOH  suggests using topical repellent prod-
cts, registered at the National Health Surveillance Agency
ANVISA). It is important to instruct the patients to follow
he recommendations on the label and to spray insect
epellent on top of the clothing. Researches demonstrate
afety of n-diethyl-meta-toluamide (DEET)-based repellents.
onetheless, other substances are also used in Brazil, such
s hydroxyethyl isobutyl piperidine carboxylate (icaridin
r picaridin) and ethyl butylacetylaminopropionate (IR3535
r EBAAP), and essential oils such as citronella. Even if
hese products are safe for regular use, there are no stud-
es in pregnant women. The CDC informs that repellents
ontaining DEET, picaridin, IR3535, some oil of lemon euca-
yptus and para-menthane-diol products provide long lasting
rotection.44,53
Besides repellent topical use, other forms of prevention are
lso important. It is suggested, whenever possible, the use of
ong clothes to protect the largest body surface as possible
gainst mosquito’s bites. Places and times with the presence
f mosquitoes should be avoided, consequently it is important
o stay in locations with barriers against the entry of insects,
ainly in the period between sunset and dawn, as protective
creens, mosquito nets, and air conditioning.44,50
In case of any alteration in the health condition of pregnant
omen, especially until the fourth month of pregnancy, it
hould be reported for the health professional.51 It is impor-
ant to posit that defects in the CNS may also be caused by
ther conditions and diseases, such as toxoplasmosis, rubella,
buse of alcohol and illicit drugs during pregnancy, and also
enetic syndromes that make differential diagnosis with those
onditions associated with ZIKV.5
onclusion
he relation between ZIKV infection during pregnancy and
icrocephaly in neonates was established by the Brazil-
an MOH. Therefore, more  attention regarding Aedes sp. is
equired, since it transmits this disease, which has more  disas-
rous consequences than DENV infection. Also, the pregnant
oman should be concerned about exposure to endemic
reas, and if possible, avoid remaining in such locations. Since
here is still no evidence about the period of vulnerability
f the embryo’s development, the protection by using repel-
ents in an epidemic situation is crucial throughout pregnancy.
otably, it is worth emphasizing that more  research is warr-
nted to study viral mechanisms of action on newborns and
n their development, because although microcephaly can be
asily diagnosed in the delivery room, other possible damage
o the fetus can be not so evident.
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